In addition, although several clinicopathological features, such as tumor progression and postoperative seizure outcome, have been reported related to molecular markers, especially, BRAF mutations, future studies are also needed to confirm these data in a larger, well-matched cohort of LEATs and to further investigate possible relationships between clinicopathological features and other molecular markers of LEAT entities as well. Here, BRAF is linked to neoplasm.